Mining of adverse event signals associated with inclisiran: a post-marketing analysis based on FAERS
This study enhanced our understanding of AEs to inclisiran. Future research on its long-term real-world use will offer insights into its safety.
Authors
- Xiaocan Jia (ORCID: https://orcid.org/0000-0002-8690-2667)
- Xuezhong Shi (ORCID: https://orcid.org/0000-0002-1694-1011)
- Nana Wang (ORCID: https://orcid.org/0000-0001-7990-4675)
- Ying Qiao (ORCID: https://orcid.org/0000-0002-5211-3109)
- Shangxin Shi
- Guibin Shen
- Yongli Yang (ORCID: https://orcid.org/0009-0000-9124-936X)
- Yi Zhang (ORCID: https://orcid.org/0000-0001-6223-4724)
Institutions
- Zhengzhou University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1080/14740338.2024.2409707
- Citations
- 3
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.05